NEW YORK (GenomeWeb) – D-Mark Biosciences will distribute Sygnis' TruePrime Single Cell WGA kit in Canada as part of a non-exclusive deal that Sygnis announced today.

D-Mark will promote, market, and sell the kit, which eliminates the need for synthetic random primers in whole-genome amplification. The kit is based on the recently discovered DNA primase TthPrimPol and the Phi29 polymerase and is the first of a number of anticipated products under the TruePrime name, Sygnis said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.